These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3756883)

  • 1. Immunospecific eosinophil infiltration of a mouse mammary carcinoma.
    Vaage J; Pepin KG; Au TL
    Cancer Res; 1986 Oct; 46(10):5344-8. PubMed ID: 3756883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary tumor immune enhancement in mice by local hyperemia.
    Vaage J
    Cancer Res; 1986 Jan; 46(1):386-9. PubMed ID: 3940204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological observations during developing concomitant immunity against a C3H/He mammary tumor.
    Vaage J; Pepin KG
    Cancer Res; 1985 Feb; 45(2):659-66. PubMed ID: 3967241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective serum effects in tumor immunity.
    Vaage J
    Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cell infiltrate of the primary tumor as a source of early systemic protection against metastases in mice.
    Vaage J; Pepin KG
    J Natl Cancer Inst; 1983 Jul; 71(1):147-55. PubMed ID: 6345879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A time factor in the success or failure of immune rejection of transplanted tumors.
    Vaage J
    Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic aspects of fibrosis in mouse mammary carcinomas.
    Vaage J
    Int J Cancer; 1992 Jan; 50(1):69-74. PubMed ID: 1728615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
    Vaage J; Agarwal S
    Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract]   [Full Text] [Related]  

  • 10. Local and systemic effects during interleukin-2 therapy of mouse mammary tumors.
    Vaage J
    Cancer Res; 1987 Aug; 47(16):4296-8. PubMed ID: 3496962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.
    Pericle F; Giovarelli M; Colombo MP; Ferrari G; Musiani P; Modesti A; Cavallo F; Di Pierro F; Novelli F; Forni G
    J Immunol; 1994 Dec; 153(12):5659-73. PubMed ID: 7989764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of the anticoagulated host's immune response to the presence of an implanted spontaneous C3H/HeJ mouse mammary tumor.
    Liter M; Knapp K; Avila J; Costo M; Eckstrand B; Fan P; Kumasaka D; Matsuura G; Namba M; Romeo D
    Proc West Pharmacol Soc; 1985; 28():229-35. PubMed ID: 4070253
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between tumor growth characteristics and preferential sites of growth.
    Vaage J
    J Natl Cancer Inst; 1984 May; 72(5):1199-203. PubMed ID: 6585595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system].
    Iunker VM; Arkhipov SA; Gruntenko EV
    Biull Eksp Biol Med; 1984 Nov; 98(11):598-600. PubMed ID: 6509179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An essential role for antibody in neutrophil and eosinophil recruitment to the cornea: B cell-deficient (microMT) mice fail to develop Th2-dependent, helminth-mediated keratitis.
    Hall LR; Lass JH; Diaconu E; Strine ER; Pearlman E
    J Immunol; 1999 Nov; 163(9):4970-5. PubMed ID: 10528201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL
    J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-H-2 restriction specificity of tumor-regressor mouse sera with regard to their activity to inhibit tumor cell transplantation.
    Egawa K; Kiyohara T; Tanino T
    Jpn J Exp Med; 1982 Oct; 52(5):255-60. PubMed ID: 7169670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherent changes in the in vivo growth characteristics of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1980 Oct; 40(10):3495-3501. PubMed ID: 7438036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.